Hsbc Holdings PLC Acquires 26,018 Shares of Viemed Healthcare, Inc. $VMD

Hsbc Holdings PLC lifted its position in Viemed Healthcare, Inc. (NASDAQ:VMD) by 193.8% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 39,443 shares of the company’s stock after acquiring an additional 26,018 shares during the quarter. Hsbc Holdings PLC owned 0.10% of Viemed Healthcare worth $291,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in the company. Russell Investments Group Ltd. lifted its holdings in shares of Viemed Healthcare by 16.6% in the 1st quarter. Russell Investments Group Ltd. now owns 200,789 shares of the company’s stock worth $1,462,000 after acquiring an additional 28,584 shares during the last quarter. Nuveen LLC bought a new stake in shares of Viemed Healthcare in the 1st quarter worth about $787,000. R Squared Ltd lifted its holdings in shares of Viemed Healthcare by 276.5% in the 1st quarter. R Squared Ltd now owns 19,110 shares of the company’s stock worth $139,000 after acquiring an additional 14,034 shares during the last quarter. GSA Capital Partners LLP lifted its holdings in shares of Viemed Healthcare by 497.7% in the 1st quarter. GSA Capital Partners LLP now owns 149,791 shares of the company’s stock worth $1,090,000 after acquiring an additional 124,731 shares during the last quarter. Finally, Corton Capital Inc. lifted its holdings in shares of Viemed Healthcare by 45.4% in the 1st quarter. Corton Capital Inc. now owns 14,842 shares of the company’s stock worth $108,000 after acquiring an additional 4,634 shares during the last quarter. Institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Price Performance

Viemed Healthcare stock opened at $6.82 on Friday. The firm has a 50-day moving average price of $6.80 and a 200-day moving average price of $6.95. The firm has a market capitalization of $264.55 million, a PE ratio of 20.06 and a beta of 1.38. The company has a current ratio of 1.48, a quick ratio of 1.37 and a debt-to-equity ratio of 0.02. Viemed Healthcare, Inc. has a 12-month low of $5.93 and a 12-month high of $9.81.

Viemed Healthcare (NASDAQ:VMD) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.08 EPS for the quarter, hitting the consensus estimate of $0.08. The company had revenue of $63.06 million for the quarter, compared to the consensus estimate of $63.50 million. Viemed Healthcare had a net margin of 5.80% and a return on equity of 10.38%.

Insider Buying and Selling

In related news, President Michael Moore sold 50,090 shares of the firm’s stock in a transaction dated Tuesday, August 12th. The shares were sold at an average price of $7.33, for a total value of $367,159.70. Following the transaction, the president owned 126,343 shares of the company’s stock, valued at $926,094.19. This trade represents a 28.39% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, VP Jerome Cambre sold 4,880 shares of the firm’s stock in a transaction dated Wednesday, August 13th. The shares were sold at an average price of $7.32, for a total transaction of $35,721.60. Following the transaction, the vice president directly owned 84,191 shares in the company, valued at $616,278.12. This trade represents a 5.48% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 97,922 shares of company stock valued at $703,886 in the last 90 days. Company insiders own 20.00% of the company’s stock.

Viemed Healthcare Profile

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.